Literature DB >> 21225799

Does HPV have a presence in diffuse high grade pre-malignant lesions of the larynx?

Heather H Waters1, Rahul Seth, Aaron P Hoschar, Michael S Benninger.   

Abstract

OBJECTIVE: To describe the incidence of HPV in diffuse high grade pre-cancerous lesions of the larynx.
METHODS: Patient charts were searched for those who presented between October 2008 and June 2009 with diffuse vocal fold leukoplakia. Biopsy proven laryngeal lesions with high grade dysplasia or carcinoma-in-situ (CIS) were examined for patient characteristics and presence of high-risk type HPV detected by in situ hybridization technique.
RESULTS: Fifteen patients with precancerous lesions were identified. Average age was 63 years and 13 were male. One lesion was identified as positive for high-risk HPV, all other lesions were negative. At current follow up, no patient has demonstrated progression to invasive carcinoma.
CONCLUSION: HPV may not play a role in non-progressing diffuse high-grade lesions of the larynx.

Entities:  

Mesh:

Year:  2010        PMID: 21225799     DOI: 10.1002/lary.21668

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  3 in total

1.  Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: What is New in the 2017 WHO Blue Book for Tumours of the Hypopharynx, Larynx, Trachea and Parapharyngeal Space.

Authors:  Nina Gale; Mario Poljak; Nina Zidar
Journal:  Head Neck Pathol       Date:  2017-02-28

Review 2.  Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Hypopharynx, Larynx, Trachea and Parapharyngeal Space.

Authors:  Nina Zidar; Nina Gale
Journal:  Head Neck Pathol       Date:  2022-03-21

Review 3.  European Laryngological Society position paper on laryngeal dysplasia Part I: aetiology and pathological classification.

Authors:  Edward Odell; Hans Edmund Eckel; Ricard Simo; Miquel Quer; Vinidh Paleri; Jens Peter Klussmann; Marc Remacle; Elisabeth Sjögren; Cesare Piazza
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-10-13       Impact factor: 2.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.